Neuroscience

Improving prediction of Parkinson's disease

Including genetic markers in addition to well known risk factors improves tests to predict Parkinson's disease, according to a study led by Queen Mary University of London.

Medications

FDA approves lumryz for narcolepsy

The U.S. Food & Drug Administration has approved Lumryz for the treatment of cataplexy or excessive daytime sleepiness in adults with narcolepsy. Lumryz is an extended-release formulation of sodium oxybate to be taken once ...

Sleep disorders

Flinders sleep experts try new tactic to fight fatigue

In a world-first, sleep experts from Flinders University are attempting to fight fatigue caused by insomnia and obstructive sleep apnoea (OSA) by treating the two conditions at the same time.

page 3 from 8